Equibles does not estimate personal net worth.
Michael Rice was last confirmed as Board Member at Biolife Solutions Inc (BLFS) in a filing dated April 30, 2021. Earlier roles on record: CEO and Chairman at Biolife Solutions Inc (BLFS) until October 19, 2023. Biolife Solutions Inc reported in an 8-K filed October 23, 2023 that Michael Rice retired as Chief Executive Officer. Biolife Solutions Inc reported in an 8-K filed October 23, 2023 that Michael Rice retired as Chief Executive Officer, effective October 19, 2023. Biolife Solutions Inc reported in an 8-K filed October 23, 2023 that Michael Rice resigned as Chairman of the Board of Directors, effective October 19, 2023. Equibles holds 4 filed executive changes naming Michael Rice; each is listed under recent activity with its source filing. The proxy statement of Biolife Solutions Inc reports total compensation of $4,900,455 for Michael Rice in fiscal 2023, including a base salary of $567,200. Disclosed compensation is on record for 6 fiscal years. Michael Rice has spoken on 3 earnings calls across 1 company, most recently for Biolife Solutions Inc on May 10, 2023. The companies whose calls Michael Rice spoke on are classified in the Healthcare sector.
“Roderick de Greef has been appointed as Chairman of the Board of Directors and Chief Executive Officer replacing Michael Rice who is retiring after a seventeen year tenure, effective immediately.”
“Roderick de Greef has been appointed as Chairman of the Board of Directors and Chief Executive Officer replacing Michael Rice who is retiring after a seventeen year tenure, effective immediately.”
“I'd like to begin our call by discussing our announcement today that we are actively exploring strategic alternatives for our Stirling ULT and Custom Biogenic Systems Cryogenic Freezer businesses, which could include out-licensing our proprietary IP, changing our go-to-market approach, and outright divesting these…”
“Q3 was another quarter of solid execution and growth despite the challenges all of us are facing due to COVID-19. We grew top-line revenue over 70%, gained 56 new customers.”
“Q2 was another quarter of solid execution and growth, despite the challenges all of us are facing due to COVID-19.”
2021-07-13–2023-10-19
Start not stated–2021-04-30
Last confirmed by a filing; no departure on record
Start not stated–2023-10-19
Medical Instruments & Supplies · Healthcare
Board Member, CEO, Chairman
2021-07-13–2023-10-19
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Biolife Solutions Inc (BLFS) | Former Chief Executive Officer and Chairman of the Board | $567,200 | $4,900,455 |
| 2022 | Biolife Solutions Inc (BLFS) | Former Chief Executive Officer and Chairman of the Board | $645,000 | $4,729,170 |
| 2021 | Biolife Solutions Inc (BLFS) | Former Chief Executive Officer and Chairman of the Board | $641,019 | $2,249,907 |
| 2020 | Biolife Solutions Inc (BLFS) | Chief Executive Officer and Chairman of the Board | $514,712 | $1,478,511 |
| 2019 | Biolife Solutions Inc (BLFS) | Chief Executive Officer and Chairman of the Board | $530,000 | $2,241,770 |
| 2018 | Biolife Solutions Inc (BLFS) | President, Chief Executive Officer and Director | $450,000 | $691,397 |
